FdaApplication
ANDA 202845
Identifiers
- fda_app_no: ANDA202845
Properties
| Property | Value |
|---|---|
| applicant_name | HERITAGE PHARMA LABS INC |
| application_type | ANDA |
| approval_date | 2012-03-08 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DIFLUNISAL | DIFLUNISAL | 250MG | TABLET;ORAL |
| DIFLUNISAL | DIFLUNISAL | 375MG | TABLET;ORAL |
| DIFLUNISAL | DIFLUNISAL | 500MG | TABLET;ORAL |
3 products